Cite
HARVARD Citation
Shen, J. et al. (n.d.). FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle. Annals of the rheumatic diseases. p. 697. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shen, J. et al. (n.d.). FRI0322 Rationale for the atacicept dose for a phase iii study in patients with highly active and auto-antibody positive sle. Annals of the rheumatic diseases. p. 697. [Online].